نتایج جستجو برای: warfarin therapy

تعداد نتایج: 660238  

Journal: :Postgraduate Medical Journal 1980

Journal: :Stroke 2006
Elena Birman-Deych Martha J Radford David S Nilasena Brian F Gage

BACKGROUND AND PURPOSE More than 2 million Americans have atrial fibrillation, and without antithrombotic therapy, their stroke rate is increased 5-fold. In randomized controlled trials, warfarin prevented 65% of ischemic strokes (hazard ratio [HR], 0.35; 95% CI, 0.26 to 0.48) compared with no antithrombotic therapy. However, the effectiveness of warfarin therapy outside of clinical trials is u...

2017
Salihah Aidit Yee Chang Soh Chuan Seng Yap Tahir M. Khan Chin Fen Neoh Shazwani Shaharuddin Yaman W. Kassab Rahul P. Patel Long C. Ming

Objective: To evaluate the impact of pharmacist-led warfarin management and standardized treatment protocol. Methods: A retrospective cohort study was carried out in a cardiology referral hospital located in central Kuala Lumpur, Malaysia, from 2009 to 2014. The inclusion criteria were: adult patients who were diagnosed and treated for atrial fibrillation (AF) with warfarin, attended the warfar...

Journal: :Circulation journal : official journal of the Japanese Circulation Society 2011
Masahiro Yasaka

nce patients with non-valvular atrial fibrillation (NVAF) develop cardioembolic stroke, the neurological symptoms are often severe and outcome is poor. Prevention of cardioembolic stroke is, therefore, important in those with NVAF, and warfarin for those with a CHADS2 score ≥2 is recommended and for those with a CHADS2 score of 1 it may be considered, according to the 2008 guideline of the Japa...

Journal: :The Canadian journal of hospital pharmacy 2015
Tammy J Bungard Angela Gee

Warfarin is a commonly used anticoagulant for the primary or secondary prevention of thrombotic events.1 Tremendous inter-individual variability in warfarin dosing is apparent, necessitating frequent monitoring via the international normalized ratio (INR). The most feared complication of warfarin therapy is major bleeding, and the risk of this problem increases when the INR exceeds 4.0.2 Critic...

Journal: :Chest 1986
H J Levine S G Pauker M H Eckman

Whether antithrombotic therapy in elderly patients differs from that in younger populations depends on whether the risk for such bleeding differs in the elderly. Regarding long-term therapy with warfarin derivatives, evidence shows that there is a difference. The anticoagulation response to warfarin is exaggerated with advancing age. This article discusses antithrombotic therapies for valvular ...

Journal: :The Medical journal of Australia 2004
Anthony E Dear Faye Gray Keith Byron

For most warfarin indications, the target maintenance international normalised ratio (INR) is 2-3. Risk factors for bleeding complications with warfarin use include age, history of past bleeding and specific comorbid conditions. To reverse the effects of warfarin, vitamin K(1) can be given. Immediate reversal is achieved with a prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP)...

Journal: :The New England journal of medicine 2003
Clive Kearon Jeffrey S Ginsberg Michael J Kovacs David R Anderson Philip Wells Jim A Julian Betsy MacKinnon Jeffrey I Weitz Mark A Crowther Sean Dolan Alexander G Turpie William Geerts Susan Solymoss Paul van Nguyen Christine Demers Susan R Kahn Jeannine Kassis Marc Rodger Julie Hambleton Michael Gent

BACKGROUND Warfarin is very effective in preventing recurrent venous thromboembolism but is also associated with a substantial risk of bleeding. After three months of conventional warfarin therapy, a lower dose of anticoagulant medication may result in less bleeding and still prevent recurrent venous thromboembolism. METHODS We conducted a randomized, double-blind study, in which 738 patients...

2018
Takanori Ikeda Masahiro Yasaka Makoto Kida Miki Imura

Purpose Although warfarin has historically been the standard of care for preventing ischemic stroke in patients with nonvalvular atrial fibrillation (NVAF), the use of direct oral anticoagulants (DOACs) is rapidly increasing. In this study, we examined the demographic and clinical characteristics of patients continuing warfarin therapy and investigated reasons for warfarin continuation. Patie...

Journal: :Circulation. Cardiovascular quality and outcomes 2016
Zhi-Zun Wang Xin Du Wei Wang Ri-Bo Tang Jing-Guang Luo Chao Li San-Shuai Chang Xiao-Hui Liu Cai-Hua Sang Rong-Hui Yu De-Yong Long Jia-Hui Wu Rong Bai Nian Liu Yan-Fei Ruan Jian-Zeng Dong Chang-Sheng Ma

BACKGROUND Despite its therapeutic efficacy, warfarin is extremely underused in Chinese patients with nonvalvular atrial fibrillation (AF). Whether the nonpersistence of warfarin treatment contributes to its underuse is not known. The aims of this study were to determine nonpersistence rates of newly started warfarin treatment in Chinese patients with nonvalvular AF and to identify the factors ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید